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Abstract
The aim when designing a scaffold is to provide a supportive microenvironment for the
native cells, which is generally achieved by structurally and biochemically imitating the
native tissue. Decellularized extracellular matrix (ECM) possesses the mechanical and
biochemical cues designed to promote native cell survival. However, when dec-
ellularized and reprocessed, the ECM loses its cell supporting mechanical integrity and
architecture. Herein, we propose dissolving the ECM into a polymer/solvent solution
and electrospinning it into a fibrous sheet, thus harnessing the biochemical cues from
the ECM and the mechanical integrity of the polymer. Bovine aorta and myocardium
were selected as ECM sources. Decellularization was achieved using sodium dodecyl
sulfate (SDS), and the ECM was combined with polycaprolactone and hexafluoro-
2-propanol for electrospinning. The scaffolds were seeded with human umbilical vein
endothelial cells (HUVECs). The study found that the inclusion of aorta ECM increased
the scaffold's wettability and subsequently lead to increased HUVEC adherence and
proliferation. Interestingly, the inclusion of myocardium ECM had no effect on wetta-
bility or cell viability. Furthermore, gene expression and mechanical changes were
noted with the addition of ECM. The results from this study show the vast potential of
electrospun ECM/polymer bioscaffolds and their use in tissue engineering.
K E YWORD S
electrospinning, endothelial cells, extracellular matrix, polycaprolactone, scaffold
1 | INTRODUCTION
In 2015, cardiovascular disease killed around 630,000 people in the
United States, accounting for 23.4% of all deaths (Heron, 2017).
Approximately 80% of those deaths fell in the category of over 65 year
olds (Heron, 2017). One of the major reasons for the increase in people
requiring sophisticated and complex cardiac interventions is the ever
increasing average life expectancy across the world's population
(Blanche et al., 2001). For example, it was found that between 1999
and 2010, in excess of 83% of over 60 year olds in the USA were found
to have hypertension or prehypertension symptoms (Guo, He, Zhang, &
Walton, 2012). Alongside this, over 7.6 million premature deaths were
noted globally in 2001 due to cardiovascular disease, with this number
rising (Lawes, Vander, & Rodgers, 2008; Makridakis & DiNicolantonio,
2014). With such a high prevalence in the elderly population and a
Abbreviations: ANOVA, analysis of variance; CD31/PECAM1, platelet endothelial cell
adhesion molecule; DAPI, 40 ,6-diamidino-2-phenylindole; ECM, extracellular matrix;
EDTA, ethylenediaminetetraacetic acid; FBS, fetal bovine serum; FTIR, Fourier transform
infrared spectroscopy; GAPDH, glyceraldehyde 3-phosphate dehydrogenase;
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rapidly increasing global ageing population, it is of no surprise that the
demand for vascular treatments is increasing (United Nations, 2015).
There are currently a large variety of vascular tissue engineering
strategies utilized in the treatment of arterial disease (Ravi & Chaikof,
2010). These include scaffold materials that mimic the native extracellu-
lar matrix (ECM), promote ECM production, reduce inflammation and
thrombogenicity, and stimulate neovascularization and angiogenesis
(Jiang, Akgun, Lam, Ameer, & Wertheim, 2015; Ravi & Chaikof, 2010).
Materials used in vascular tissue engineering include decellularized
extracellular matrices, biopolymers, bioabsorbable polymers, and colla-
gen (Gilbert, Sellaro, & Badylak, 2006; Hong et al., 2008; Hutmacher,
2000; Jiang et al., 2015; Lu, Lin, Kim, et al., 2013; Masoumi et al., 2014;
Reid & Callanan, 2019; Wu, Liu, Cui, Qu, & Chen, 2007). Electrospinning
is a widely used technique that mimics the nanoscale and microscale
structure of tissues and has been utilized in a large number of tissue
engineering avenues for various organs (Burton & Callanan, 2018; Bur-
ton, Corcoran, & Callanan, 2017; Dettin et al., 2015; Gao et al., 2017;
Garrigues, Little, Sanches-Adams, et al., 2014; Grant, Hay, & Callanan,
2017; Han, Gerstenhaber, Lazarovici, & Lelkes, 2013; Hong et al., 2008;
Kumbar, Nukavarapu, James, Nair, & Laurencin, 2008; Masoumi et al.,
2014; Sundaramurthi, Krishnan, & Sethuraman, 2014). Furthermore,
while polymers can control architecture, they lack some of the unique
biomolecular cues found in native tissue, which is why, in recent years,
there has been an increase in demand for decellularized ECM (Kasimir
et al., 2006; Sanchez, Fernandez-Santos, Costanza, et al., 2015; Tapias &
Ott, 2014; Weymann, Patil, Sabashnikov, et al., 2014). The ECM is the
pivotal factor in the intracellular microenvironment, thus it plays a major
role in maintaining and regulating tissue function (Kang, Kim,
Khademhosseini, & Yang, 2011). Therefore, incorporating components
of the ECM into a scaffold to more closely mimic the native environment
is an effective way to promote tissue regeneration (Bhowmick et al.,
2017; Choi et al., 2010). While there have been huge advances in the
treatment of cardiovascular disease, there is still a large demand to
increase patency and surgical outcome.
Hybrid scaffolds that incorporate ECM with a polymer into a spun
fiber have shown improved cellular performance when using meniscus
and cartilage (Gao et al., 2017; Garrigues et al., 2014). Other methods of
manufacturing scaffolds/constructs using vascular ECM and polymers
have ranged from repopulating aortic valves to vascular grafts in the car-
diovascular realm (Schoen, Avrahami, Baruch, et al., 2017). Interestingly,
studies focusing on vascular ECM have shown improvements in native
cell repopulation and mechanical properties when combining the ECM
with a polymer (Hong et al., 2008; Jahnavi, Kumary, Bhuvaneshwar,
Natarajan, & Verma, 2015; Jiang et al., 2015; Wu et al., 2007). Further-
more, electrospinning was successfully utilized to generate these hybrid
structures that showed increased mechanical strength and improved cel-
lular repopulation (Hong et al., 2008; Jahnavi et al., 2015; Wu et al.,
2007). These previous studies combining vascular ECM and polymers to
create hybrid scaffolds show promising results, with improvements in
cellular performance noted in most cases.
Current treatments are not keeping up with the increased demand
for surgery and transplantation (Blanche et al., 2001; Kilic, Emani,
Sai-Sudhakar, Higgins, & Whitson, 2014). Herein, we propose
incorporating the native vascular ECM into the electrospun polymer
fibers via solubilization of the ECM. By combining heart and aorta
ECM with polycaprolactone (PCL), the aim is to manufacture an
improved platform for the attachment and growth of endothelial cells,
with the aim of improving vascular regeneration.
2 | MATERIALS AND METHODS
2.1 | ECM production
Bovine heart and aorta were harvested from a 2-year-old female. Sam-
ples were frozen within 4 hr of harvesting at −80C. Heart tissue was
sliced up into 5-mm-thick slices using a meat slicer. The aorta was
opened up and flattened out and subsequently had 40-mm-circular sam-
ples punched out. This was repeated for the heart slices. Slices were
cleaned with ethanol and placed in water for 30 min to remove excess
blood. Samples were then cut up into 2 mm × 2 mm square pieces to
increase surface area for decellularization. Pieces were perfused with
0.5% w/v sodium dodecyl sulfate (SDS) in deionized water for 36 hr at
170 mL/min. Samples were then perfused with 10 L of deionised water
at 170 mL/min. Decellularized samples were then frozen at −80C
before being lyophilized in a FreeZone® 4.5 freeze-drier (Labconco®).
Dry ECM was then crushed up into ~0.5 mm pieces before being milled
in a planetary ball mill PM 100 (Retsch). ECM powder was then collected
in water, frozen at −80C, and lyophilized leaving behind ECM powder.
Powder was stored at 4C.
2.2 | Histology
Native and decellularized samples of bovine heart and aorta were
fixed in 10% formalin for 24 hr. Samples were then dehydrated in a
series of ethanol washes starting at 50% concentration and ending at
100% concentration. Samples were washed in xylene before being
embedded in paraffin wax and then stored at 4C. All samples were
then trimmed to 5 μm thicknesses and mounted onto glass slides for
haematoxylin and eosin (H&E) staining and Picrosirius Red staining.
Samples were cleared in xylene before staining and mounted in Dis-
tyrene Plasticizer Xylene (DPX) after staining.
2.2.1 | Haematoxylin and eosin staining
Samples were cleared of paraffin before undergoing rehydration in a
series of ethanol and H2O washes. Samples were stained in
haematoxylin for 6 min and Eosin for 90 s, leading to a vivid pink color
for the eosinophilic substances (cell cytoplasm and ECM proteins) and
a dark blue/black for the nuclear substances (cell nucleus).
2.2.2 | Picrosirius red staining
Samples were cleared of paraffin before undergoing rehydration in a
series of ethanol and H2O washes. Samples were stained in 0.1% Sirius
Red for 1 hr, leading to a vivid red color for the collagenous substances
(ECM) and a dull yellow color for the cellular substances (cell cytoplasm
and cell nucleus) (Velidandla, Gaikwad, Ealla, et al., 2014).
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2.3 | Scaffold manufacture (electrospinning)
Powdered heart or aorta ECM was dissolved at 0.25% w/v in hexa-
fluoroisopropanol (HFIP). PCL was then dissolved at 8% w/v into the
HFIP/ECM solution overnight with agitation. The solutions were
placed into a 20 mL syringe and pumped using a syringe pump
EP-H11 (Harvard Apparatus) into the EC-DIG electrospinning system
(IME Technologies). PCL/ECM scaffolds were electrospun using the
following parameters: 0.4 mm needle bore, 0.8 mL/hr volume flow
rate (6 mL in total), 12 cm mandrel: needle distance, +14 kV positive
charge, −4 kV negative charge, and 250 revolutions per minute man-
drel rotational speed. These parameters have been shown to create
uniform randomly aligned small fibers of PCL (Burton et al., 2017).
The mandrel was coated with aluminum foil for collection. Once col-
lected, the electrospun sheet was left to dry for 24 hr in the hood
before being stored at 4C. Scaffolds were punched out using a
10 mm punch and left in ethanol for 30 min to sterilize and assist with
removal from the aluminum foil. The 0.25% ECM scaffolds had final
PCL:ECM ratios of 96.97:3.03 (approximated to 97:3 for simplicity).
This ratio was deduced from the remnant PCL:ECM ratio left over
once the solvent had left the solution, which was 8% w/v PCL:0.25%
w/v ECM. The electrospinning process is shown in Figure 1.
2.4 | Scanning electron microscopy
Both unseeded and seeded scaffolds were visualized at day 0 and day
10 using a Hitachi S4700 fueled emission scanning electron micro-
scope (SEM, Hitachi) with a 5 kV accelerating voltage and a working
distance of 12 mm. Briefly, the day 10 seeded scaffolds (n = 2) were
fixed in 4% v/v glutaraldehyde overnight, before being stored in phos-
phate buffer saline (PBS) at 4C for 3 days. Scaffolds were then incu-
bated in 0.1% v/v osmium for 30 min, followed by four rinses in
DiH2O. Samples were then dehydrated in ethanol using 30 s intervals
of increasing ethanol concentration from 30 to 100% v/v to achieve
critical point drying. Scaffolds were then placed in HDMS for 1 min.
HDMS was then replaced and left to evaporate overnight in a fume
cupboard. Prior to imaging, all scaffolds were sputter coated using an
Emscope SC500A splutter coater using gold–palladium (60:40).
The process of glutaraldehyde fixation followed by Osmium
tetroxide staining allows for clear viewing of the cellular membrane
and ECM components on the scaffold. Glutaraldehyde fixation causes
rapid crosslinking of the proteins within the cells (Hopwood, 1972).
Osmium tetroxide is then used as a lipid stain by embedding a heavy
metal directly into the cell membrane, thus creating a high electron
scattering rate allowing for clear visualization of the cell membrane
(Thiery, Bernier, & Bergeron, 1995).
2.5 | Mechanical testing
An Instron 3,367 tensile testing machine (Instron, UK) with a 50 N load
cell was used to test scaffolds in tension. Young's modulus of the scaf-
folds was assessed on unseeded scaffolds and on scaffolds after 10 days
of culture. Briefly, 20 mm × 4 mm strips of scaffold were cut out for
mechanical testing. These samples had a gauge length of 14 mm and
were stretched at 10 mm/min until failure or 200% strain was achieved.
The incremental Young's modulus was deduced by using the formula:
E =
FL0
AΔL
where E is Young's modulus, F is the applied force, A is the cross sectional
area, ΔL is change in length, and L0 is the original length. Data were ana-
lyzed using a previously described analysis method. Briefly, incremental
Young's moduli are calculated to show how stiffness changes with
increasing strain (Burton et al., 2017; Burton & Callanan, 2018; Callanan,
Davis, McGloughlin, Walsh, 2014a; Callanan, Davis, Walsh, &
McGloughlin, 2012; Munir, Larsen, & Callanan, 2018; Munir, McDonald, &
Callanan, 2019; Santoro et al., 2018) (N = 5 independent replicates).
2.6 | Contact angle measurement
Samples were measured using dry scaffolds. Briefly, a single 5-μL drop-
let of water was placed on the scaffold, and images were captured at
5 Hz using a DMK 41AU02 monochrome 1,280 × 960 camera. Analysis
was done using ImageJ software with a previously developed plugin:
LBADSA (Stalder et al., 2010), as seen in Figure 2 (N = 5).
2.7 | Fourier transform infrared spectroscopy
Fourier transform infrared spectroscopy (FTIR) was used to confirm
the successful inclusion of vascular ECMs into the electrospun PCL
F IGURE 1 Electrospinning setup. The polymer/solvent solution is
drawn across from the Taylor cone formed at the needle tip to the
charged rotating mandrel. As the solution is drawn across, it
transitions from a liquid into a solid fiber that attaches itself to the
rotating mandrel
F IGURE 2 Representative images showing the LBADSA plugin on
ImageJ measuring contact angle on a hydrophobic (>90 contact angle)
and hydrophilic (<90 contact angle) sample (ΘCA = contact angle)
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fibers. Samples were cut into 6-mm-diameter scaffolds. All spectra
were obtained using a Nicolet™ iS™10 spectrometer with a Smart™
iTX diamond attenuated total reflection detector (all from Thermo
Fisher Scientific). Spectra were acquired between 4,000 and
400 cm−1 with a resolution of 1 cm−1 using OMNIC™ Spectra
software (Thermo Fisher Scientific) (N = 5 independent replicates).
2.8 | Cell growth
Human umbilical vein endothelial cells (HUVECs) from an infant male
Caucasian donor were obtained cryopreserved at passage 1 (Pro-
moCell GmbH) and expanded to passage 7 in a 5% CO2/37C
atmosphere. HUVECs were expanded using MCBD 131 medium (Life
Technologies) supplemented with 5% v/v fetal bovine serum (FBS;
ThermoFisher Scientific); 1% v/v L-glutamine; 1% v/v penicillin/strepto-
mycin (Life Technologies); 1 mg/L hydrocortisone; 50 mg/L ascorbic
acid (Sigma); 2 μg/L fibroblast growth factor (PeproTech); 10 μg/L
epidermal growth factor (PeproTech); 2 μg/L insulin-like growth factor
(PeproTech); and 1 μg/L vascular endothelial growth factor (PeproTech)
(Callanan, Davis, McGloughlin, Walsh, 2014b; Carroll, McGloughlin,
O'Keeffe, et al., 2009; Davis et al., 2014).
2.9 | Cell seeding and culture
Scaffolds were punched out using a 10 mm punch and left in 70% v/v
ethanol for 30 min before being seeded. Scaffolds were plated into a
48 well plate and were then presoaked in serum free MCDB
131 medium (same cocktail as cell growth medium minus FBS) over-
night to increase their hydrophilicity. Cells were seeded at 35,000
cells per scaffold. Briefly, a 35,000 cell suspension in 20 μL of medium
was dropped onto the middle of the scaffold and left for 30 min,
before an additional 30 μL of medium was added to ensure that the
cells did not dry up. After another 30 min, 450 μL of medium was
added, increasing the total volume of media to 500 μL. Seeded
scaffolds were fed every 2 days using the same MCBD 131 medium
cocktail as previously described.
Scaffolds for mechanical testing were cut out at 20 mm × 4 mm and
seeded at the same seeding density as the 1-mm-diameter scaffolds.
2.10 | CellTiter-blue® cell viability assay
The assay was performed at 1, 5, and 10 days as the manufacturer's
instructions (Promega). Briefly, scaffolds were moved into new media
in a fresh 48-well plate to prevent reading the activity of cells bound
to the tissue culture plastic. Measurements were made with a
Modulus™ II microplate reader at Excitation 525 nm and Emission
580–640 nm (N = 4 independent replicates).
2.11 | DNA quantification
Cell seeded scaffolds cultured for 1, 5, and 10 days were frozen and
lyophilized before being incubated in a papain digest solution of 2.5 U
papain, 5 mM cysteine HCL, and 5 mM EDTA in DNA free water (all
reagents from Sigma-Aldrich, UK) at 60C for 24 hr and periodically
mixed using a vortexer. Total DNA content of the samples was calcu-
lated using a Quant-iT™PicoGreen® assay kit (ThermoFisher, UK) as
per the manufacturers' instructions. Fluorescence was read using a
Modulus™ II microplate reader at Excitation 490 nm and Emission
510–570 nm (N = 4 independent replicates).
2.12 | Cell imaging
Scaffolds were washed thrice in PBS and fixed using 500 μL of 4% v/v
formalin solution in PBS for 24 hr, then washed again three times in
PBS. Permeabilization achieved by placing scaffolds in 0.2% v/v
TritonX-100 solution in PBS for 5 min, followed by three PBS washes.
Scaffolds were stained with 0.1 mL of 0.1 μL 1000X Phalloidin-
iFluor™514 conjugate (AAT Bioquest, Stratech) in 0.1 mL PBS with
1% v/v bovine serum albumin for 60 min. Scaffolds were washed
thrice in PBS for 10 min. Scaffolds were then stained with 0.1 mL of
300 nM 40,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, UK) in
PBS for 10 min followed by three 10 min PBS washes.
All scaffolds were imaged using a Coherent Anti-Stokes Raman
scattering microscope.
2.13 | Real-time RT-qPCR
RNA was extracted from the scaffolds using standard Tri-Reagent
(Invitrogen, ThermoFisher) methods and purified using Qiagen's
RNeasy spin column system. Real-time polymerase chain reaction was
performed using a LightCycler® 480 Instrument II (Roche Life Science)
and Sensifast™ SYBR® High-ROX system (Bioline). Forward and
reverse sequences were designed with Sigma-Aldrich and are dis-
played in Table 1 (Callanan et al., 2014b; Fischer et al., 2009). Relative
quantification of Reverse transcription polymerase chain reaction (RT-
PCR) results was carried out using the 2−ΔΔct method (Livak &
Schmittgen, 2001). Gene expression levels were expressed relative to
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (housekeeping
gene) and normalized to expression on the day 1 PCL control.
2.14 | Statistical analysis
Data were expressed as mean ± 1 SD, unless stated otherwise. Statistical
analysis was performed using one-way analysis of variance (ANOVA)
with post hoc Fisher test for DNA content, CellTiter-Blue®, and real-time
qPCR, unless stated otherwise. One-way ANOVA with post hoc Fisher's
test has been widely used in literature when comparing a large range of
variable sizes (Bédouin, Gordin, Pellen-Mussi, et al., 2018; Nayak &
Brenner, 2002; Vogels et al., 2017; Woods & Gratzer, 2005).
3 | RESULTS
3.1 | Decellularization and scaffold manufacture
Bovine heart and aorta ECM were successfully decellularized using 0.5%
w/v SDS as seen in Figure 3a. H&E staining showed that the cells were
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TABLE 1 The sequences for forward and reverse gene specific primers used in RT-PCR amplification
Gene Primer Sequence
Sequence
length Reference
Glyceraldehyde 3-phosphate
dehydrogenase
GAPDH (forward) GTCTCCTCTGACTTCAACAG 20 (Callanan et al. 2014b)
GAPDH (reverse) GTTGTCATACCAGGAAATGAG 21
Matrix metalloproteinase-1 MMP1 (forward) CGGTTTTTCAAAGGGAATAAGTACT 25 (Callanan et al. 2014b)
MMP1 (reverse) TCAGAAAGAGCAGCATCGATATG 23
Matrix metalloproteinase-2 MMP2 (forward) CGCTCAGATCCGTGGTGAG 19 (Callanan et al. 2014b)
MMP2 (reverse) TGTCACGTGGCGTCACAGT 19
Vascular endothelial growth factor VEGF (forward) AGACCAAAGAAAGATAGAGCAAGACAAG 28 (Callanan et al. 2014b)
VEGF (reverse) GGCAGCGTGGTTTCTGTATCG 21
Platelet endothelial
cell adhesion molecule
CD31 (forward) ACTGGACAAGAAAGAGGCCATCCA 24 (Fischer et al. 2009)
CD31 (reverse) TCCTTCTGGATGGTGAAGTTGGCT 24
F IGURE 3 (a) DNA content of aorta and
heart before and after decellularizing
treatment. Data shown as mean ± 1 SD,
student 2 sample t-test performed (**p < .01,
***p < .001, and n = 4). (b) H&E staining and
Picrosirius red staining of the aorta and heart
tissue before and after decellularization. H&E
staining shows a vivid pink color for the
eosinophilic substances (cell cytoplasm and
ECM proteins) and a dark blue/black color for
the nuclear substances (cell nucleus).
Picrosirius red staining shows a vivid red color
for the collagenous substances (ECM) and a
dull yellow color for the cellular substances
(cell cytoplasm and cell nucleus). ECM,
extracellular matrix; H&E, haematoxylin and
eosin
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successfully removed from both tissues (see Figure 3b). Furthermore,
Picrosirius red staining showed that the collagenous composition of the
ECM was maintained after decellularization (Figure 3b). Electrospun
fibrous sheets (as seen in Figure 4) were successfully fabricated using
the previously described parameters (Burton et al., 2017). The fibers
within each scaffold are fairly uniform in size (fiber diameters of 0.97
± 0.19, 1.20 ± 0.09, and 0.94 ± 0.12 μm, respectively, for the PCL, heart
ECM, and aorta ECM scaffolds) and show a randomness in their orienta-
tion. Furthermore, the fibers appear to be smooth in structure.
3.2 | Fourier Transform Infrared Spectroscopy
The FTIR results showed that the bovine heart and aorta ECMs were
incorporated into the electrospun PCL fibers. Spectra were taken for
PCL fibers, ECM/PCL fibers, and ECM alone. Characteristic peaks
from both the PCL and ECM were found in the ECM/PCL fibers dem-
onstrating that the electrospinning process integrated the dec-
ellularized ECM into the PCL fiber. Figure 5 shows peaks in
absorbance at 1720, 1654, and 1,541 cm−1 for both heart and aorta
ECM (See Supplementary Figure S1 in the appendix for overlay graphs
of all five samples for each group). These peaks can be attributed to
the stretching of the carbonyl group in PCL, the amide I bond in the
ECM, and the amide II bond in the ECM, respectively (Camacho, West,
Torzilli, & Mendelsohn, 2001; Elzein, Nasser-Eddine, Delaite, Bistac, &
Dumas, 2004; Garidel & Schott, 2006). These values are shown in
Table 2. Furthermore, differences in absorbance values between PCL
only scaffolds and the PCL/ECM scaffolds were quantified at each
wavelength to show that the differences were observed due to the
inclusion of ECM. Briefly, increases of 84.3 ± 8.0% (p < .01) and
109.2 ± 18.6% (p < .01) were seen at 1654 and 1,541 cm−1, respec-
tively, for the aorta ECM, with a decrease of 19.4 ± 15.5% (p < .05) at
1720 cm−1. The heart ECM showed increases of 35.2 ± 6.7% (p < .01)
and 26.8 ± 10.7% and a decrease of 10.5 ± 15.2% for the three wave-
lengths. These values are displayed in Table 3.
3.3 | Mechanical testing
Mechanical testing performed using an Instron tensile tester showed no
statistically significant difference between cell seeded and unseeded
scaffolds for each scaffold at all the strain bands. However, the general
trend for the PCL scaffold and the heart ECM scaffold is a slightly higher
Young's modulus in the seeded scaffolds then the unseeded scaffold, as
seen in Table 4. However, as previously mentioned, this difference is not
significant. The only statistical significance is in the aorta ECM scaffold
for the 3–4% strain band, where the seeded scaffold was significantly
lower than the unseeded scaffold (p < .05). The general trend noted is
that the two ECM scaffolds had consistently higher Young's moduli at all
strain brackets compared with the PCL control. This was significant at
F IGURE 4 Scanning electron
microscopy images of the three
electrospun sheets. All three scaffolds
appear to have a smooth fiber structure
and show relatively uniform fiber
diameter throughout (fiber diameters of
0.97 ± 0.19, 1.20 ± 0.09, and 0.94
± 0.12 μm, respectively, for the PCL,
heart ECM, and aorta ECM scaffolds).
ECM, extracellular matrix;
PCL, polycaprolactone
F IGURE 5 Representative FTIR
absorbance spectra for (a) aorta ECM
scaffolds and (b) heart ECM scaffolds.
ECM, extracellular matrix; FTIR, Fourier
transform infrared spectroscopy
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the 0–1% strain band for both scaffolds where the heart ECM was
23.2% higher and aorta ECM 28.4% higher (p < .05); and the 1–2% strain
band for aorta ECM which was 31.0% higher (p < .05). As expected,
Young's modulus drops at each subsequent strain bracket for all the scaf-
fold (with the exception of unseeded aorta ECM scaffold between the
0–1% and 1–2% strain brackets). Representative stress–strain graphs for
each scaffold are displayed in Figure 6a.
3.4 | Contact angle
The addition of aorta ECM had the effect of increasing the hydrophi-
licity of the scaffold compared with the conventional PCL scaffold and
heart ECM scaffold, as seen in Table 4. These results were significant
when comparing the aorta ECM scaffold with the heart ECM
scaffold—26.9% lower (p < .05), but not when comparing either with
the PCL scaffold. Furthermore, the percentage drop in contact angle
between 0.2 s postcontact and 5 s postcontact was higher for the
aorta ECM scaffold than the two others.
3.5 | Cell viability and DNA quanitification
Cell viability was assessed using a CellTitre-Blue® fluorescence assay.
Results (Figure 6b) showed that after 10 days, the aorta ECM scaffold
and the heart ECM scaffold both showed a significant increase in cell
TABLE 2 Absorbance values for each peak
Wavelength
of peak (cm−1)
Absorbance values
PCL Aorta ECM Heart ECM
1,720 0.774 ± 0.110 0.624 ± 0.040 0.693 ± 0.039
1,654 0.025 ± 0.001 0.046 ± 0.004 0.034 ± 0.002
1,541 0.011 ± 0.001 0.023 ± 0.004 0.014 ± 0.001
Abbreviations: ECM, extracellular matrix; PCL, polycaprolactone.
TABLE 3 Wavelength of peaks noted
in FTIR spectra
Wavelength
of peak (cm−1) Assignment Caused by
Change in absorbance between
PCL fiber and ECM/PCL fiber
Aorta ECM Heart ECM
1,720 Carbonyl group
stretching
PCL − 19.4 ± 15.5% − 10.5 ± 15.2%
1,654 Amide I bond ECM (collagen
and elastin)
+ 84.3 ± 8.0% + 35.2 ± 6.7%
1,541 Amide II bond ECM (collagen
and elastin)
+ 109.2 ± 18.6% + 26.8 ± 10.7%
Abbreviations: ECM, extracellular matrix; PCL, polycaprolactone.
TABLE 4 Mechanical properties of the three scaffolds
Scaffold type
PCL Heart ECM Aorta ECM
Unseeded Seeded Unseeded Seeded Unseeded Seeded
Young's modulus at % strain (MPa)
0–1 17.05 ± 1.81 19.48 ± 2.14 21.00 ± 1.87 22.58 ± 2.13 21.90 ± 2.93 21.60 ± 1.91
1–2 16.80 ± 1.27 18.10 ± 2.21 20.87 ± 2.60 20.68 ± 2.37 22.00 ± 3.11 18.76 ± 1.95
2–3 15.03 ± 1.89 15.25 ± 2.47 16.27 ± 2.22 18.18 ± 1.62 18.04 ± 2.29 15.82 ± 1.12
3–4 13.93 ± 1.53 14.55 ± 3.00 15.96 ± 1.69 15.84 ± 1.60 17.34 ± 1.95 14.30 ± 0.85
4–5 12.45 ± 1.75 13.08 ± 2.80 12.64 ± 1.40 14.16 ± 1.18 14.90 ± 1.76 12.92 ± 0.64
0–5a 15.05 ± 1.54 16.09 ± 2.49 17.35 ± 1.83 18.29 ± 1.72 18.84 ± 2.28 16.68 ± 1.26
Contact angle after 0.2 s (degree) 114.4 ± 8.9 122.5 ± 3.5 89.6 ± 37.7
Contact angle after 1 s (degree) 103.6 ± 19.6 118.8 ± 10.7 72.8 ± 43.9
Contact angle after 5 s (degree) 98.7 ± 25.2 106.3 ± 27.2 68.8 ± 43.6
Percentage drop in contact angle
between 0.2 and 1 s
9.44% 3.02% 18.75%
Percentage drop in contact angle
between 0.2 and 5 s
13.72% 13.22% 23.21%
Fiber diameter (μm) 0.97 ± 0.19 1.20 ± 0.09 0.94 ± 0.12
Note: Values displayed ± 1 SD.
Abbreviations: ECM, extracellular matrix; PCL, polycaprolactone.
aYoung's modulus across the entire strain range from 0 to 5% strain.
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viability compared with viability after 1 day (p < .05). The aorta ECM
scaffold also showed a significant increase compared with its viability
after 5 days (p < .01). On the other hand, the PCL scaffold showed no
significant increase in cell viability between all three time points,
although an upward trend in cell viability is noted. After 10 days, the
aorta ECM scaffold had a 40% higher cell viability than the heart ECM
and the PCL scaffold. However, this increase was not found to be
significant.
DNA quantification was performed using a Picogreen assay. The
DNA content (Figure 6c) of the aorta ECM scaffolds at 10 days is
significantly different from the aorta ECM scaffold at day 1 (a 275%
increase). Alongside this, the day 10 aorta ECM scaffold was also
significantly higher by approximately 240% than the heart ECM and
PCL scaffolds (p < .05). The trend noted across the three time points
is an increase in DNA content for all three scaffolds, but a larger
increase in the aorta ECM scaffolds.
3.6 | Cell imaging
Representative SEM images taken using a Hitachi S4700 fuelled emis-
sion SEM (Hitachi) show the functional cell layers on scaffolds after
10 days of culture (Figure 7a). Interestingly, the aorta ECM scaffold
appears to be 100% confluent with HUVECs, compared with approxi-
mately 30% for the PCL scaffold and 50% for the heart ECM scaffold.
These results validate the cell viability and DNA quantification results,
suggesting that the incorporation of aorta ECM into the scaffold
improved HUVEC proliferation. Furthermore, all three scaffolds show
similar HUVEC morphology.
Representative images taken using coherent antistoke Raman scat-
tering further confirm that the incorporation of aorta ECM into the
scaffold had a favorable effect on HUVECs (Figure 7b). After 1 day of
growth, the cells on the aorta ECM scaffold already appear greater in
number and have a higher quantity of visible actin filaments. The heart
ECM scaffolds show very poor cell attachment after 1 day, which
matches the cell viability and DNA quantification results. Furthermore,
cell number appears to increase for all scaffolds between day 1 and day
10. Interestingly, the actin filaments appear more characterized after
10 days, which is a sign of maturing cells (Huber et al., 2013).
3.7 | Gene analysis
Multiple genes associated with vascular function were assayed for
their expression, including cluster of differentiation (CD31), matrix
metalloproteinase-1 (MMP1), matrix metalloproteinase-2 (MMP2), and
vascular endothelial growth factor (VEGF) (Figure 8). Statistical signifi-
cance was noted in CD31 expression changes, with downregulation
observed for all three scaffolds between day 1 and day 5. Within the
day 1 scaffolds, the heart ECM scaffold showed higher CD31 expres-
sion than the two other scaffolds. MMP1 expression showed down-
regulation over time for all three scaffolds, with the biggest reduction in
expression seen for the aorta ECM scaffold. Significantly lower expres-
sions were also noted for the aorta ECM scaffolds at 5 and 10 days
when compared with the two other scaffolds. Conversely, MMP2
expression was seen to increase over time, with significant increases
for the PCL and heart ECM scaffolds. Furthermore, the aorta ECM scaf-
fold had a significantly higher expression at day 1 compared with the
PCL and heart ECM scaffolds. VEGF showed no real trend over time,
with the only exception being that aorta ECM scaffold had a signifi-
cantly higher expression than the heart ECM scaffold at day 1.
4 | DISCUSSION
Polymer scaffolds have long been utilized in tissue engineering as a plat-
form for tissue regeneration (Dhandayuthapani, Yoshida, Maekawa, &
Kumar, 2011; O'Brien, 2011; Saha, Pollock, Schaffer, & Healy, 2007).
Physical characteristics can be designed into the scaffold to support cel-
lular activity and promote differentiation, proliferation, and deposition
F IGURE 6 (a) Representative stress versus strain graphs of each scaffold—Unseeded and after 10 days of HUVEC culture. (b) Cell viability of
scaffolds analyzed using CellTitre blue® fluorescence assay. A statistically significant increase in cell viability was seen in the heart ECM and aorta
ECM scaffolds between day 1 and day 10. (c) DNA content of scaffolds assessed using a Picogreen assay. The aorta ECM showed the largest
increase in DNA content between day 1 and day 10 and showed a significantly higher DNA content than the PCL scaffold and heart ECM
scaffold at day 10. n = 4, error bars = 1 SD, one-way ANOVA with Fishers' post hoc performed (*p < .05 and **p < .01). ANOVA, analysis of
variance; ECM, extracellular matrix; HUVEC, human umbilical vein endothelial cell
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of new functional ECM (O'Brien, 2011). In this study, we have used PCL
as the polymer component as it is commonly used in tissue engineering
due to its physical and chemical properties, especially in electrospinning
where it has been used in a variety of tissue engineering applications
(Burton et al., 2017; Dunphy, Reid, Burton, et al., 2018; Gao et al.,
2017; Grant et al., 2017; Sundaramurthi et al., 2014). Alongside poly-
mers, decellularized tissue has been used in tissue engineering due to its
cell-supporting physical and chemical characteristics (Lu et al., 2013;
Tapias & Ott, 2014). The aim when decellularizing is to maintain the
physical and chemical characteristics of the remnant ECM (Gilbert et al.,
2006). In this study, we used SDS (at a concentration of 0.5%), which is
a commonly used ionic detergent for decellularizing tissues (Nakayama,
Batchelder, Lee, & Tarantal, 2010; Oberwallner et al., 2014; Ott et al.,
2008; Ott et al., 2010; Ross, Williams, & Batich, 2009) and successfully
reduced DNA content approximately 8–14 fold across the two tissue
types (Figure 3a). It is a very effective means of removing nuclear com-
ponents and cytoplasmic proteins (Woods & Gratzer, 2005) and has
been used with varying concentrations ranging from 0.1 to 4%, with
results showing complete removal of cellular material while maintaining
structural integrity and a network of laminin and collagen (Nakayama
et al., 2010; Oberwallner et al., 2014; Ott et al., 2008; Ott et al., 2010;
Ross et al., 2009). H&E staining confirmed the removal of the DNA con-
tent from the two tissue types after decellularization, and the Picrosirius
red staining confirmed that the collagenous structure of the ECM was
maintained during decellularization (Figure 3b). The FTIR results for the
two ECMs showed peaks in the areas associated with structural
F IGURE 7 (a) Representative SEM
images of scaffolds and a functional layer
of HUVEC cells. The aorta ECM scaffold
showed 100% confluence after 10 days of
culture compared with approximately 30%
for the PCL scaffold and 50% for the heart
ECM scaffold. (b) Representative coherent
antistoke Raman scattering (CARS) images
of HUVECs on all three scaffolds at 1 day
and 10 days. DAPI staining (blue) highlights
the cells nucleus. Phalloidin staining (green)
highlights the actin filaments which are
predominantly found in the cell cytoplasm.
PCL scaffold fibers (white). ECM,
extracellular matrix; HUVEC, human
umbilical vein endothelial cell; SEM,
scanning electron microscope; PCL,
polycaprolactone
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proteins such as collagen and elastin, suggesting that the decellularizing
process maintained the protein's integrity (Cheheltani, McGoverin, Rao,
et al., 2014).
As previously described, polymers and ECM both have their advan-
tages when used as scaffolds for tissue engineering (Dhandayuthapani
et al., 2011; Tapias & Ott, 2014). In this study, we have combined the
two in an attempt to harness the beneficial characteristics from each to
create a bioscaffold more suited for vascular tissue engineering.
Recently, work has focused on combining the two to take advantage of
these characteristics, in a similar vein to this study (Gao et al., 2017;
Hong et al., 2008; Jahnavi et al., 2015; Jiang et al., 2015; Wu et al.,
2007). For example, coating vascular ECM with polymers has been
implemented before, with the aim of improving biochemical and
mechanical performance (Jahnavi et al., 2015; Wu et al., 2007). These
studies both noted improved mechanical properties. However, the final
structure of the scaffold is limited by the size and architecture of the
ECM. By integrating the ECM directly into the polymer fibers, as we
have done in this study using electrospinning, we are able to create a
highly tailored and physically repeatable structure that both includes
the biochemical cues found in native ECM, and has the mechanical
strength of the electrospun polymer. Moreover, as found in this study
and previous, there are mechanical and biochemical benefits to combin-
ing ECM with polymers (Jahnavi et al., 2015; Wu et al., 2007).
The inclusion of ECM into the PCL fibers was confirmed through
the use of FTIR. The two PCL/ECM scaffolds shared absorbance peaks
with the PCL only scaffold and the ECM alone. These peaks were noted
at 1720, 1654, and 1,541 cm−1, and have assignments with the car-
bonyl group in PCL, and the amide I and amide II groups found in ECM
(Camacho et al., 2001; Elzein et al., 2004). The changes in absorbance
found at these peaks due to the addition of the two ECMs were quanti-
fied, as shown in Tables 2 and 3, and were found to be in line with what
we would expect from literature (Gao et al., 2017).
The technique proposed in this study solubilizes vascular ECMs
into a PCL/HFIP solution; a method previously used with dec-
ellularized meniscus and cartilage ECM (Gao et al., 2017; Garrigues
et al., 2014). Gao et al. used a range of PCL and meniscus ECM con-
centrations up to 8 and 6% w/v, respectively. While this ECM concen-
tration is substantially higher than the ones used in this study, they
found that the addition of ECM had a positive effect in reducing con-
tact angle, a phenomena also noted with the inclusion of aorta ECM
in this study. Similarly, Garrigues et al. dissolved decellularized carti-
lage ECM into a solution of PCL and HFIP at 8% w/v, showing that
ECM could successfully be incorporated into an electrospun polymer
fiber and provide a platform for cell growth (Garrigues et al., 2014).
Gene expression changes were observed with the addition of cartilage
ECM, in similar vein to this study. We have shown that the same pro-
cedure can be used with vascular tissues, with the incorporation of
ECM altering mechanical and cellular performance.
The inclusion of ECM into the electrospun polymer fibers had the
effect of increasing the scaffold's tensile Young's modulus, as noted in
Table 4. Significant differences were seen at the 0–1% strain band for
both scaffolds where the heart ECM was 23.2% higher and aorta
ECM 28.4% higher, and the 1–2% strain band for aorta ECM which
was 31.0% higher. This can be explained by these native vascular
ECMs being made up of constituent proteins such as collagen, which
has been found to have much higher stiffnesses at lower strains than
F IGURE 8 Real time qPCR data using
the 2−ΔΔCt method showing the
expression of four genes (MMP1, MMP2,
CD31, and VEGF) relative to GAPDH. All
results are normalized to the PCL scaffold
on day 1. N = 5, data shown as mean ± 1
SD, one-way ANOVA with Fishers' post
hoc performed (*p < .05 and **p < .01).
ANOVA, analysis of variance; CD31,
cluster of differentiation; GAPDH,
glyceraldehyde 3-phosphate
dehydrogenase; MMP1, matrix
metalloproteinase-1; MMP2, matrix
metalloproteinase-2;
PCL, polycaprolactone
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PCL alone (bulk properties), 1–21 GPa for collagen compared with
300–400 MPa for PCL (Eshraghi & Das, 2010; Wenger, Bozec,
Horton, & Mesquida, 2007). Interestingly, this phenomenon has also
been noted when electrospinning combinations of liver ECM, fibro-
nectin, and collagen with polylactic acid (Grant, Hallett, Forbes, et al.,
2019). They found that the scaffold's Young's modulus increased by
between 13 and 66% depending on which protein was blended (Grant
et al., 2019).
A trend of decreasing MMP1 expression for all three scaffolds was
noted. MMP1 is an enzyme involved in the breakdown and remodeling
of collagen (one of the major components of vascular ECMs) (Batra
et al., 2012). Its downregulation suggests that the cells are not trying to
breakdown the collagen within the ECM, suggesting that they are in a
position of homeostatic equilibrium with their scaffold. A significant
downregulation was noted across all three scaffolds between day 1 and
day 5, with no real change between day 5 and day 10. Interestingly, the
largest downregulation was noted in the aorta ECM scaffold. While this
downregulation may suggest that there is a change in collagen content
within the ECM scaffolds, similar trends were noted between the ECM
scaffolds and the PCL only scaffold suggesting that scaffold architecture
is likely the biggest driver in gene expression and that the ECM is hav-
ing a limited effect on gene activity.
In contrast, a significant upregulation of MMP2 was noted in all
three scaffolds after 5 and 10 days. Furthermore, after 1 day, a signifi-
cantly higher expression was seen in the aorta ECM scaffold com-
pared with the two other scaffolds. This enzyme is involved in the
breakdown and remodeling of gelatin (another major component of
vascular ECMs) (Wiseman et al., 2003). Its upregulation suggests the
presence of gelatin in the ECM scaffolds. We noted an upregulation
across both ECM scaffolds, as well as the PCL only scaffold after
10 days of culture, with no significant differences noted between the
three scaffolds. This suggests that this upregulation is unlikely to be
caused by the presence of gelatin in the ECM scaffolds and is proba-
bly a result of something other than the constituents of the two
native ECMs, such as scaffold architecture, as previously mentioned.
On the other hand, no real trend in VEGF expression was noted.
VEGF is a signal protein that stimulates the formation of new blood ves-
sels (angiogenesis) in tissue regeneration (Ferrara, Gerber, & LeCouter,
2003). Its overexpression is also associated with tumor growth and
intraocular neovascular disorders (Ferrara et al., 2003). During cellular
proliferation, an upregulation of VEGF would be expected (Nayak &
Brenner, 2002). It has been suggested that HUVECs “overexpress”
VEGF in the first 24 hr, which may explain this down regulation over
time compared with the day 1 scaffolds (Imaizumi et al., 2000).
A downward trend in CD31 expression was seen for all three scaf-
folds. CD31, also known as PECAM1 (platelet endothelial cell adhe-
sion molecule 1) is a protein found on the surface of many cells and is
involved in angiogenesis and integrin activation. Overexpression of
CD31 can inhibit morphogenesis in cells (Sheibani & Frazier, 1998). Its
downregulation suggests that: the HUVECs are struggling to adhere
to each other (Baldwin, Shen, Yan, et al., 1994), which SEM and fluo-
rescence microscopy images disprove, or the HUVECs are not
attempting to create new vasculature (angiogenesis) (Wang et al.,
2016). This is the most likely reason that can be attributed to the issue
of poor cellular infiltration which is required in order to achieve full
tissue regeneration. A lack of infiltration in this study resulted in a
monolayer of cells growing on the surface of the scaffold. Studies
have shown the contribution of porosity and pore interconnectivity
on cell survival and HUVEC angiogenesis (Munir & Callanan, 2018;
Xiao, Wang, Liu, et al., 2015). Despite this, the ECM scaffolds in this
study are still viable platforms for cell attachment, and cellular infiltra-
tion can be improved by either increasing the mean pore diameter
(Murphy, Haugh, & O'Brien, 2010; Phipps, Clem, Grunda, Clines, &
Bellis, 2012; Wu & Hong, 2016), or by increasing the hydrophilicity of
the scaffold through plasma treatment and the addition of functional
groups (Burton et al., 2017; Dettin et al., 2015), two easily applicable
techniques.
In this study, there was a noticeable trend in the data suggesting
that the aorta ECM scaffold had enhanced adhesive properties com-
pared with the two other scaffolds. DNA quantification and cell viabil-
ity were both higher for the aorta ECM scaffold at 24 hr. The FTIR
results showed a greater increase in absorbance at the amide I and
amide II peaks when aorta ECM was added to the fiber compared with
when heart ECM was added to the fiber. FTIR is a surface analysis
method that has been shown to measure to depths ranging from 0.2
to 5 μm (Kazarian & Chan, 2013). The fibers in this study are approxi-
mately 1 μm thick suggesting that the shifts in absorbance may be
due to the location of the ECM within the fiber. Higher absorbance in
the aorta ECM scaffolds may be caused by the ECM mobilizing onto
the surface of the fibers, where they would be more readily picked up
by FTIR. Furthermore, the aorta ECM scaffold was found to have a
lower contact angle than the two other scaffolds, which has been
shown to result in higher cell adhesion and proliferation (Dowling,
Miller, Ardhaoui, & Gallagher, 2011; Gao et al., 2017). The differences
in contact angle may be due to the components of ECM at the fiber
surface increasing the surface energy of the scaffold (Faucheux,
Schweiss, Lützow, Werner, & Groth, 2004).
There are some limitations to this work. First, a thorough investi-
gation of electrospinning in HFIP's denaturing effect on the ECM is
required. Previous studies have shown that HFIP can have a denatur-
ing effect on various proteins, including collagen (Agarwal,
Wendorff, & Greiner, 2008; Herskovits, Gadegbeku, & Jaillet, 1970;
Zeugolis et al., 2008), with one study suggesting that approximately
45% of the triple helical structure of collagen became denatured (and
becoming gelatin) when dissolved in HFIP (Yang et al., 2008), which
would suggest that the ECM used in this study could be denatured.
They also found that pure collagen fibers were water soluble when
they were not crosslinked, suggesting that crosslinking would increase
the integrity of electrospun protein fibers (Yang et al., 2008). How-
ever, it has also been shown that crosslinking electrospun ECM pro-
tein scaffolds drastically alters their morphology, often leading to
large reductions in porosity (Heydarkhan-Hagvall et al., 2008), which
has been shown to negatively impact certain cells (Badylak & Gilbert,
2008; Lowery, Datta, & Rutledge, 2010). Furthermore, PCL/gelatin
blended scaffolds have shown loss of protein when cultured in both
PBS and cell culture medium (Marrese, Cirillo, Guarino, et al., 2018).
REID AND CALLANAN 11
They found that surface roughness increased over a culture period of
9 days due to the gelatin dissolving from the scaffold and interestingly
found that this was more pronounced in culture medium than in PBS
(Marrese et al., 2018). Likewise, collagen/elastin/polymer (elastin and
collagen being the two most prominent ECM proteins) blends with
approximately 75% crosslinking have shown varying degrees of
mechanical integrity when in culture conditions. Over the course of
8 weeks of culture, reductions in inner diameter ranging from 10%
(PCL and PLLA) to 70% (PLCL) were seen depending on the polymer
used. This reduction in mechanical integrity could potentially be
explained by the dissolution of collagen and elastin from the scaffold
fibers. In addition to this, the electric field which the ECM particles
are subjected to may also have a denaturing effect. It has been shown
that high voltages can alter the structure of proteins (Freedman, Haq,
Edel, et al., 2013). Therefore, while both collagen denaturing and pro-
tein dissolution are possible during processing, the retained bioactivity
from the ECM within the scaffold outweighs the losses seen (Badylak,
Freytes, & Gilbert, 2009; Choudhury, Tun, Wang, & Naing, 2018).
SDS has been shown to induce protein denaturing and requires
further study on its effects with vascular ECMs (Bhuyan, 2010). While
this study did show the successful maintenance of collagen in both
tissues after decellularization (Picrosirius Red staining in Figure 3b),
other ECM proteins such as elastin were not looked at. However,
studies have shown successful decellularization using SDS without
damaging the components of the ECM (Garrigues et al., 2014; He &
Callanan, 2013; Oberwallner et al., 2014; Sullivan et al., 2012).
Furthermore, a thorough proteomic study of the ECM components
and the cellular secretome would act as validation for the PCR results
and would give a better understanding of which proteins lead to the
improved adhesive properties (Chang, Dalgliesh, Lopez, et al., 2016;
Hathout, 2007). Further analysis on how the ECM was incorporated
into the electrospun fibers is required. Studies have shown contradic-
tory results with some showing complete protein integration into the
fibers (Gao et al., 2017; Garrigues et al., 2014), and others showing
globular protein microparticles in the fibers (Chakrapani, Gnanamani,
Giridev, Madhusoothanan, & Sekaran, 2012). However, the studies
which incorporated ECM into electrospun fibers, along with this
study, showed improvements in cellular and mechanical performance,
suggesting that there is a large potential for these hybrid bioscaffolds
in tissue engineering.
5 | CONCLUSION
In this study, we have shown that the integration of decellularized
vascular ECM into an electrospun polymer fibers has promise for
vascular tissue engineering applications. We successfully combined
decellularized ECM from bovine myocardium and aorta into a
PCL/HFIP solution and electrospun it into a network of fibers. Our
results show that the inclusion of these ECMs had both effects on the
performance of seeded HUVECs and on the mechanical characteris-
tics of the scaffold. Cell viability was shown to increase with the inclu-
sion of aorta ECM in the scaffold. Furthermore, Young's modulus was
increased through the addition of both vascular ECMs, and hydrophi-
licity was increased with the addition of aorta ECM. The inclusion of
aorta ECM resulted in a stiffer scaffold that had improved biomechan-
ical properties for the attachment of cells—leading to the increased
cell adherence noted in this study. The method we have described
combines the controllable physical properties of the polymer (PCL)
with the biochemical and mechanical properties of the ECM (aorta
and myocardium wall) to create a tailored hybrid bioscaffold. We
believe that the combination of a natural ECM and a synthetic poly-
mer to generate a hybrid bioscaffold has many potential applications
in vascular tissue engineering.
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